饮食质量作为肝功能酶异常的关联因素 在生殖年龄妇女中
Fatehatun Noor1,2, Nusrat Jahan Shorovi1, Md Mahadi Hasan Shoruve1
1Institute of Nutrition and Food Science, University of Dhaka, Dhaka, BGD.
Cureus
|March 3, 2026
概括
饮食质量差,以低食物消费分数 (FCS) 为标志,与孟加拉妇女肝酶 (ALT和AST) 的升高有关. 改善饮食对肝脏健康和预防非传染性疾病至关重要.
科学领域:
- 营养与公共卫生 营养与公共卫生
- 肝病学 肝病学是一种肝病学.
- 流行病学 流行病学
背景情况:
- 非酒精性脂肪肝 (NAFLD) 和肝酶 (ALT,AST) 的升高是越来越多的健康问题,特别是在孟加拉国妇女中.
- 快速的饮食转向高能量食物加剧了非传染性疾病 (NCD) 的负担.
研究的目的:
- 研究孟加拉国生育年龄妇女的饮食摄入量,饮食质量指标和肝酶 (ALT和AST) 升高之间的关联.
主要方法:
- 一项涉及孟加拉国240名女性 (15-49岁) 的横截面研究.
- 通过24小时回忆和食物频率问卷 (FFQ) 评估的饮食摄入量.
- 使用饮食多样性 (DD),食品消费得分 (FCS) 和孟加拉国健康饮食指数 (BD_HEI) 评估饮食质量;肝酶通过生物化学测量.
主要成果:
- 28.7%的参与者患有ALT和/或AST升高.
- 升高的肝酶与更高的和脂肪和胆固醇摄入量相关.
- 酶水平升高的参与者具有较低的FCS (p=0.014) 和较高的DD (p=0.036).
- 低FCS显著增加了肝酶升高的几率 (AOR=3.64,p=0.003).
结论:
- 在孟加拉妇女中,缺乏FCS和肝酶异常之间存在显著的关联.
- 建议将饮食质量干预措施整合到生殖健康和NCD计划中,以维持肝脏健康.
相关概念视频
Liver Physiology
3.8K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.8K
Factors Affecting Drug Biotransformation: Biological
915
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
915
Bioavailability: Influencing Factors
679
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
679
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679


